Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibition (ICI) improves survival outcomes for patients with several types of cancer including metastatic melanoma (MM), but serious immune-related adverse events requiring intervention with immunosuppressive medications occur in a subset of patients. Skin toxicity (ST...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Gulati, Nicholas, Donnelly, Douglas, Qian, Yingzhi, Moran, Una, Johannet, Paul, Zhong, Judy, Osman, Iman
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659132/
https://ncbi.nlm.nih.gov/pubmed/33176813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02612-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars